Popular Articles
Cellulite Cream

ASTRO Accepting Grant Applications From Illinois Cancer Support Organizations
The American Society for Radiation Oncology (ASTRO) is now accepting applications for Survivor Circle grants from cancer support organizations in Illinois. ASTRO awards these grants to non-disease site specific cancer support groups located in the state where ASTRO holds its Annual Meeting. ASTRO"s Annual Meeting will be held November 1-5, 2009, at McCormick Place West in Chicago.
generic viagra online
WHO, Wyeth Launch Trial In Africa To Test New River Blindness Drug
The WHO on Wednesday announced plans for a clinical trial to test a new drug that "could halve the treatment period for river blindness [or onchocerciasis], a disease that threatens 100 million people mostly in Africa," AFP/Dow Jones Newswires/CNN Money reports (7/1). "This is a devastating illness that has plagued 30 African countries for centuries, in particular the populations in the most remote areas "beyond the end of the road,"" Uche Amazigo, director of the African Programme for Onchocerciasis Control (APOC), said (ANI/Thaindian.com, 7/1).
News of the day
FDA Issues Safety Communication About An Ongoing Review Of Stimulant Medications Used In Children With ADHD
There may be an association between the use of stimulant medications for attention-deficit hyperactivity disorder, known as ADHD, and sudden cardiac death in healthy children, according to a study published in the American Journal of Psychiatry. But the U.S. Food and Drug Administration says that, because of the study"s limitations, parents should not stop a child"s stimulant medication based on the study. The FDA recommends that parents should discuss concerns about the use of these medications with the prescribing health care professional.
Nutrition

New All-Natural Capsaicin-Based, Zinc-Free Nasal Spray Is Effective In Relieving Symptoms Of Allergic Rhinitis

Researchers from Strategic BioSciences, together with investigators from the Institute for Asthma and Allergy (Wheaton, MD) reported that the new all-natural product is safe and effective in relieving symptoms of allergic rhinitis. MucoAd® is a mucoadhesive molecule (hypromellose) that prolongs contact with the nasal surface so that the nasal spray is well tolerated, lasts longer, and repeat dosing is needed less frequently. The double-blind cross-over study included 24 patients suffering from symptomatic, persistent allergic rhinitis who recorded the severity of their runny nose, itchy nose, stuffy nose and sneezing twice a day for a month. The capsaicin- MucoAd® formula (Sinol-M™) was compared to the 1st generation product without MucoAd® (Sinol™). Capsaicin nasal spray reduced all symptoms, and symptom relief was achieved with less Sinol-M than Sinol - particularly at night, suggesting that Sinol-M might permit a better night"s sleep, free from rhinitis symptoms. There were no treatment related adverse events during the study and Sinol-M was associated with less subjective reports of discomfort. "This study represents the first-ever capsaicin-based treatment for allergic rhinitis to be supported by prospective clinical data, and has important implications for millions of Americans who suffer from nasal allergies. This all-natural product has now been demonstrated to provide clinical effectiveness without any of the side effects associated with intra-nasal steroids and is available without a prescription. It may also provide a new option for patients looking for a zinc-free, all-natural product in the wake of the June 16, 2009 Food and Drug Administration (FDA) warning to consumers to stop using and discard zinc-containing intranasal products (Zicam), due to numerous reports that they may cause a loss of sense of smell (anosmia). " commented Dr. Michael A. Kaliner, of the Institute of Asthma and Allergy, Wheaton, Maryland, and principal author and presenter of this poster. Full results of the study will be published in a peer reviewed journal. Sinol™ is registered as a homeopathic product in the US. Its principal active ingredient is capsaicin, which is derived from the hot pepper plant. The 2nd generation formulation, Sinol-M™, adds a patented mucoadhesive solution (MucoAd®) that prolongs the contact between a drug and the mucosa. Sinol-M™ is now available in the US and Canada. Nasal allergies affect approximately 20% of the US population or about 50 million people, including 10%-30% of adults and up to 40% of children. The American Academy of Allergy, Asthma and Immunology (AAAAI) estimates that seasonal allergies cause over 8.2 million days of restricted activity, 3.8 million lost school and work days and 16.7 million medical office visits. Absenteeism and reduced productivity due to allergic rhinitis, specifically, is estimated, to cost US companies and the health care system more than $6 billion per year. Strategic Pharmaceuticals Company LLC


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):